2-[4-[2-(11,11-dimethylbenzo[b]fluoren-4-yl)phenyl]naphthalen-1-yl]-4,6-diphenylpyrimidine
C51H36N2 — CID 176793951
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[2-(11,11-dimethylbenzo[b]fluoren-4-yl)phenyl]naphthalen-1-yl]-4,6-diphenylpyrimidine
2-[4-[2-(11,11-dimethylbenzo[b]fluoren-4-yl)phenyl]naphthalen-1-yl]-4,6-diphenylpyrimidine (PubChem CID 176793951) has the molecular formula C51H36N2 and a molecular weight of 676.86 g/mol. Its IUPAC name is 2-[4-[2-(11,11-dimethylbenzo[b]fluoren-4-yl)phenyl]naphthalen-1-yl]-4,6-diphenylpyrimidine.
Molecular Properties
| Compound Name | 2-[4-[2-(11,11-dimethylbenzo[b]fluoren-4-yl)phenyl]naphthalen-1-yl]-4,6-diphenylpyrimidine |
|---|---|
| PubChem CID | 176793951 |
| Molecular Formula | C51H36N2 |
| Molecular Weight | 676.86 g/mol |
| Exact Mass | 676.29 |
| IUPAC Name | 2-[4-[2-(11,11-dimethylbenzo[b]fluoren-4-yl)phenyl]naphthalen-1-yl]-4,6-diphenylpyrimidine |
| SMILES | CC1(C)c2cc3ccccc3cc2-c2c(-c3ccccc3-c3ccc(-c4nc(-c5ccccc5)cc(-c5ccccc5)n4)c4ccccc34)cccc21 |
| InChI | InChI=1S/C51H36N2/c1-51(2)45-27-15-26-42(49(45)44-30-35-20-9-10-21-36(35)31-46(44)51)39-24-13-11-22-37(39)41-28-29-43(40-25-14-12-23-38(40)41)50-52-47(33-16-5-3-6-17-33)32-48(53-50)34-18-7-4-8-19-34/h3-32H,1-2H3 |
| InChIKey | MRROXNDGVXSKPY-UHFFFAOYSA-N |
| XLogP | 13.42 |
| TPSA | 25.78 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 53 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 676.86 |
| LogP ≤ 5 | 13.42 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176793951 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.